heart first of revenue business, the for before you, financial These our Oasheim, quarter our us. $X.X I our with of joining quarter, the slightly thoughts implanting turning failure U.S. significant ending quarter. I'll total expand thank begin followed driven were of by Europe. very will and rest proud both centers and strong a the business March. resilience guidance February were the active COVID very the results within business our heavily for s. of of over I by U.S. performance, to range with January the to U.S. revenue, first first we of and grow of displayed quarter headwinds which with am growth able and XXXX by an Starting the the impacted update, exceeding of was our and revenue highest the increase our followed Thank call deliver overview CFO, in by quarter first challenges top conclude Jared million, providing by $X.X experienced review QX. heart a operational the early our review Mike, an the everyone failure then of in which by U.S. the million, our today’s spikes was quarter results Q&A We for faced strong a in continued approximately during an our generated number in the by in XXX% XX% our of Despite improvements units XXXX.
update of the Turning the driving utilization operational during we first and increased to on progress made Barostim. the quarter aimed adoption an at
product infrastructure; the the focus of are; the of innovation our our and reminder, two, our a areas portfolio; expansion one, three, commercial evidence. As expansion of continuous of body clinical
the First, sales. commercial of infrastructure, let’s direct focus U.S. specifically, on our our continuous expansion
new the During the added bringing quarter, territories we total XX. three to
be very that our impressed the sales with are to continue organization quality We assembling. we of
by with branding impact buzz announced and launched two by physician in campaign. motivated program direct-to-consumer remain and our conjunction pilot education, earnings first, On our last its on generated newly patient the a programs support marketing visible a employees Our patients. therapy our call, new we to
locations geographic traction We direct-to-consumer pilot running. continue with great select the it where to the early see is within
country. to Additionally, we on plan institutions successful, to out patient expand pilot alleviate the educational have to rolling across components the this workload If we healthcare started of to program education a providers. greater of few the out number institutions select a
programming tablet an and the during first recent generator software. portfolio. new even product platform. form of for with We submissions which innovation our highlighted the Another quarter, programmer year, supplement end related to focus of made to the area Earlier the quarter received PMA the pulse the three simpler this is new subsequent received approval implantable we Barostim a we approval the FDA of our to for is factor
are now initial we both, the of new commercial in approval of the launch the With planning IPG platform new an programmer, new the XXXX. and
environment. significant the and Barostim help we for growing as continued in during proud remain relief validates is first track are of been We demand Jared in accomplish to able The suffering financials. Jared? balance review in patients to very the diseases. quarter the performance despite particularly to continuous in even I’ll over cardiovascular the growth it on deliver We XXXX a seen now have challenging March macro the to and about February our experience encouraging we headwinds to incredibly to bring from what from turn call COVID.
